TABLE 2

Beneficial effects of the mood stabilizer VPA in multiple models of CNS disorders

Preclinical studies supporting the repurposing of VPA as a modulator of neuroprotection in various animal models of CNS diseases.

DiseaseExperimental modelsReferences
Ischemic strokeRat and mouse MCAO models; rat global ischemia modelRen et al., 2004; Kim et al., 2007; Qian et al., 2010; Tsai et al., 2011; Wang et al., 2011a, 2012; Xuan et al., 2012
Hemorrhagic strokeRat intracerebral hemorrhagic modelSinn et al., 2007
TBIRat model of controlled cortical impactDash et al., 2010
HDTransgenic miceZadori et al., 2009; Chiu et al., 2011;
ADCultured cells and hippocampal slices; transgenic mice; DrosophilaSu et al., 2004; Qing et al., 2008; Smith et al., 2010; Hu et al., 2011
ALSTransgenic miceSugai et al., 2004; Rouaux et al., 2007; Feng et al., 2008
FXSFXS lymphoblastoid cell linesTabolacci et al., 2005, 2008
PDLPS-treated midbrain neuron-glia co-cultures; cellular, rat and mouse MPTP models; rotenone-challenged cellular and rat modelsPeng et al., 2005; Chen et al., 2006, 2007; Wu et al., 2008; Castro et al., 2012; Kidd and Schneider, 2010, 2011; Monti et al., 2010; Xiong et al., 2011
Retinal degenerationRat retinal ganglion cells; rat retinal ischemia model; optic nerve crush; miceBiermann et al., 2010, 2011; Zhang et al., 2011b, 2012b
Spinal cord injuryAdult rats and mice; organotypic culture of spinal cordAbematsu et al., 2010; Lv et al., 2011, 2012; Penas et al., 2011; Lee et al., 2012b
Spinal muscular atrophySMA fibroblast cell lines; transgenic miceSumner et al., 2003; Tsai et al., 2006, 2008; Harahap et al., 2012
HIV-associated neurotoxicityMouse model of encephalitis; cultured neuronsDou et al., 2005